Ece Tavukçuoğlu

Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

Shubaash Anthiya, Süleyman Can Öztürk, Ece Tavukçuoğlu et al. · Journal of Controlled Release · 2023 · 91 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

Functional exhaustion of CD4⁺ T cells induced by co‐stimulatory signals from myeloid leukaemia cells

Didem Özkazanç, Diğdem Yöyen-Ermiş, Ece Tavukçuoğlu et al. · Immunology · 2016 · 70 citations · Full text

Life Sciences, Immunology, Oncology +17

Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS

Diğdem Yöyen-Ermiş, Gürcan Tunalı, Ece Tavukçuoğlu et al. · Scientific Reports · 2019 · 59 citations · Full text

Medicine, Immunology, Oncology +17

Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

Hayrettin Tonbul, Adem Şahin, Ece Tavukçuoğlu et al. · Journal of Drug Delivery Science and Technology · 2021 · 47 citations

Pharmacy, Oncology, Pharmacology +16

Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer

Hayrettin Tonbul, Adem Şahin, Ece Tavukçuoğlu et al. · Journal of Drug Delivery Science and Technology · 2019 · 46 citations

Pharmacy, Pharmaceutics, Pharmacology +17